Skip to main content
V-Lab
V-Lab

Apimeds Pharmaceutica US Inc Asymmetric ILLIQ Liquidity Analysis

High-persistence model: shocks decay very slowly, so the theoretical long-run value may not be practically meaningful

Illiquidity prediction for Wednesday, October 21st, 2026

1 Day

228,888.00

decreased by 24,363.60

1 Week

165,004.16

decreased by 88,247.44

1 Month

255,289.60

increased by 2,038.00

Analysis last updated: Tuesday, October 20, 2026 at 10:37 PM UTC

Press Delete or Backspace to remove this series.
Date Range:

from

10/20/2024

to

10/20/2026

6M ·

1Y ·

All

graph of Apimeds Pharmaceutica US Inc ILLIQ-AMEM

News Impact Curve

How returns affect tomorrow's illiquidity

Illiquidity Forecast

How illiquidity evolves over time

Parameter Estimates

May 9, 2025 to Oct 16, 2026

Model Insight

Estimated persistence of 1.000 is at or above 1 (non-stationary): illiquidity shocks do not decay and the long-run level is undefined, so long-horizon forecasts should be treated with caution.

μ

ILLIQ-AMEM Model

Tap to view equation

High persistence: persistence 1.000 ≥ 1, shocks do not decay
ParamValuet-stat
ωconst5.0000
0.00
αARCH0.1738
1.60
βGARCH0.7834
18.35***
γleverage0.0855
0.44

1.000

Persistence

-

Half-life
μ

ILLIQ-AMEM Model

Tap to view equation

ParameterValuet-statistic
ω

const

Unconditional variance weight

5.0000
0.00
α

ARCH

Response to squared shocks

0.1738
1.60
β

GARCH

Volatility persistence

0.7834
18.35***
γ

leverage

Additional response to negative shocks

0.0855
0.44

Persistence:

1.000

Half-life:

-